» Articles » PMID: 37589859

PGT-A: Houston, We Have a Problem

Overview
Publisher Springer
Date 2023 Aug 17
PMID 37589859
Authors
Affiliations
Soon will be listed here.
Abstract

Preimplantation genetic testing for aneuploidy (PGT-A) is a common add-on to IVF cycles. As it is presently performed, PGT-A relies on whole genome amplification of small amounts of DNA from cells removed from the trophectoderm (TE) of a blastocyst for determination of gain or loss of chromosomal material by next-generation sequencing. Whole genome amplification may introduce artifacts such as allele dropout and loss of heterozygosity in up to 25% of cases. In addition, the high prevalence of mosaicism in human embryos is a complicating factor in interpreting the results of PGT-A screening. In the presence of mosaicism, biopsy of TE cells cannot provide accurate results regarding the chromosomal make-up of the inner cell mass. The available clinical data suggest that PGT-A is probably harmful when IVF outcomes are analyzed by intention to treat or by live birth rate per cycle started rather than per embryo transfer, especially in women with three or fewer blastocysts. In addition, hypothesized advantages of reduced spontaneous abortion rate and reduced time to conception may be modest at best.

Citing Articles

Does double cryopreservation as well as double biopsy affect embryo viability and clinical outcomes? Evidence from a systematic review of the literature.

Bartolacci A, Vitiello C, de Girolamo S, Papaleo E, Pagliardini L J Assist Reprod Genet. 2025; .

PMID: 39893354 DOI: 10.1007/s10815-025-03398-5.


PGT-A: what's it for, what's wrong?.

Viville S, Aboulghar M J Assist Reprod Genet. 2025; 42(1):63-69.

PMID: 39847200 PMC: 11806166. DOI: 10.1007/s10815-025-03400-0.


The most appropriate indicators of successful ovarian stimulation.

Roque M, Sunkara S Reprod Biol Endocrinol. 2025; 23(Suppl 1):5.

PMID: 39789602 PMC: 11714799. DOI: 10.1186/s12958-024-01331-6.


Novel embryo selection strategies-finding the right balance.

Polyakov A, Rozen G, Gyngell C, Savulescu J Front Reprod Health. 2024; 5:1287621.

PMID: 38162011 PMC: 10757847. DOI: 10.3389/frph.2023.1287621.

References
1.
Munne S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L . Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod. 1999; 14(9):2191-9. DOI: 10.1093/humrep/14.9.2191. View

2.
Coonen E, Van Montfoort A, Carvalho F, Kokkali G, Moutou C, Rubio C . ESHRE PGT Consortium data collection XVI-XVIII: cycles from 2013 to 2015. Hum Reprod Open. 2020; 2020(4):hoaa043. PMC: 7532546. DOI: 10.1093/hropen/hoaa043. View

3.
McCoy R . Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm. Trends Genet. 2017; 33(7):448-463. PMC: 5484399. DOI: 10.1016/j.tig.2017.04.001. View

4.
Polonis K, Lopes J, Cabral H, Babcock H, Kline L, Ruiz K . Uniparental disomy of multiple chromosomes in two cases with a complex phenotype. Am J Med Genet A. 2023; 191(7):1978-1983. DOI: 10.1002/ajmg.a.63224. View

5.
Melado Vidales L, Lawrenz B, Vitorino R, Patel R, Ruiz F, Marqueta Marques L . Clinical and laboratory parameters associated with cycle outcomes in patients undergoing euploid frozen blastocyst transfer. Reprod Biomed Online. 2023; 46(6):917-925. DOI: 10.1016/j.rbmo.2023.02.014. View